Sarepta Therapeutics Inc (NASDAQ:SRPT)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Recs

0
Player Avatar pchop123 (79.69) Submitted: 11/23/2012 1:35:10 PM : Outperform Start Price: $29.35 SRPT Score: -5.62

Next Blockbuster Stock !!!

Featured Broker Partners


Advertisement